Biomarkers of chemotherapy-induced cardiotoxicity: toward precision prevention using extracellular vesicles
Detrimental side effects of drugs like doxorubicin, which can cause cardiotoxicity, pose barriers for preventing cancer progression, or treating cancer early through molecular interception. Extracellular vesicles (EVs) are valued for their potential as biomarkers of human health, chemical and molecu...
Saved in:
| Main Authors: | Brian B. Silver, Anna Kreutz, Madeleine Weick, Kevin Gerrish, Erik J. Tokar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-04-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1393930/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanistic Insights into Flavonoid Subclasses as Cardioprotective Agents Against Doxorubicin-Induced Cardiotoxicity: A Comprehensive Review
by: Shang W, et al.
Published: (2025-07-01) -
Combined effects of metformin and coenzyme Q10 on doxorubicin-induced cardiotoxicity in male wistar rats
by: Faraz Mahdizadeh, et al.
Published: (2025-07-01) -
Characterization of extracellular vesicles and miRNA released by cerebral organoids
by: Brian B. Silver, et al.
Published: (2025-01-01) -
A review of cardioprotective effect of ginsenosides in chemotherapy-induced cardiotoxicity
by: Hadi Zare-Zardini, et al.
Published: (2024-12-01) -
Vitamin C as a Cardioprotective Agent Against Doxorubicin‐Induced Cardiotoxicity
by: Hamdi Nsairat, et al.
Published: (2025-08-01)